Su Lin

5.9k total citations · 3 hit papers
103 papers, 3.9k citations indexed

About

Su Lin is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Su Lin has authored 103 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Epidemiology, 40 papers in Hepatology and 16 papers in Surgery. Recurrent topics in Su Lin's work include Liver Disease Diagnosis and Treatment (47 papers), Liver Disease and Transplantation (28 papers) and Hepatitis B Virus Studies (13 papers). Su Lin is often cited by papers focused on Liver Disease Diagnosis and Treatment (47 papers), Liver Disease and Transplantation (28 papers) and Hepatitis B Virus Studies (13 papers). Su Lin collaborates with scholars based in China, Singapore and United States. Su Lin's co-authors include Jiaofeng Huang, Yueyong Zhu, Rahul Kumar, Valeria Culotta, Yinlian Wu, Ming-Fang Wang, Paul J. Schmidt, Robert A. Pufahl, Katrina Peariso and Christoph J. Fahrni and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Su Lin

99 papers receiving 3.8k citations

Hit Papers

Metal Ion Chaperone Function of the Soluble Cu(I) Recepto... 1997 2026 2006 2016 1997 2020 2020 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Su Lin China 26 1.4k 947 660 645 600 103 3.9k
Giuseppe Castaldo Italy 38 688 0.5× 785 0.8× 225 0.3× 1.6k 2.4× 400 0.7× 231 5.0k
Xiaoping Luo China 36 1.1k 0.8× 2.9k 3.1× 276 0.4× 1.4k 2.2× 407 0.7× 223 7.2k
Jerry Polesel Italy 52 1.8k 1.3× 655 0.7× 413 0.6× 1.5k 2.3× 579 1.0× 238 8.4k
Thomas D. Coates United States 56 892 0.7× 287 0.3× 1.1k 1.6× 971 1.5× 183 0.3× 296 9.8k
Johannes Oldenburg Germany 67 727 0.5× 522 0.6× 1.2k 1.9× 4.1k 6.3× 551 0.9× 658 18.1k
Alejandro C. Arroliga United States 44 1.0k 0.8× 511 0.5× 147 0.2× 491 0.8× 271 0.5× 168 5.9k
Yvon Berland France 43 582 0.4× 411 0.4× 411 0.6× 1.7k 2.7× 321 0.5× 213 6.2k
Victor R. Gordeuk United States 57 687 0.5× 774 0.8× 2.0k 3.0× 1.8k 2.8× 191 0.3× 401 11.8k
Maria Domenica Cappellini Italy 70 1.4k 1.1× 760 0.8× 1.6k 2.4× 2.8k 4.4× 445 0.7× 565 20.8k
Antonio Piga Italy 44 743 0.5× 259 0.3× 1.2k 1.9× 626 1.0× 298 0.5× 195 8.8k

Countries citing papers authored by Su Lin

Since Specialization
Citations

This map shows the geographic impact of Su Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Lin more than expected).

Fields of papers citing papers by Su Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Lin. The network helps show where Su Lin may publish in the future.

Co-authorship network of co-authors of Su Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Su Lin. A scholar is included among the top collaborators of Su Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su Lin. Su Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xiaoning, et al.. (2024). The PKHD1 gene inhibits tumor proliferation and invasion in intrahepatic cholangiocarcinoma by activating the Notch pathway. International Journal of Medical Sciences. 21(14). 2655–2663.
2.
Lin, Kenneth W., Rajneesh Kumar, Feng Shen, et al.. (2023). The utility of non‐invasive tests to assess advanced fibrosis in Asian subjects with chronic hepatitis B and concomitant hepatic steatosis. Liver International. 43(5). 1008–1014. 5 indexed citations
3.
Mehta, Gautam, Su Lin, Stewart Macdonald, et al.. (2023). AlcoChange: A digital therapeutic for patients with alcohol-related liver disease. JHEP Reports. 6(4). 100993–100993. 6 indexed citations
4.
Gong, Weiyuan, et al.. (2023). Functional iron deficiency anemia was associated with higher mortality in chronic kidney disease patients: the NHANES III follow-up study. Renal Failure. 45(2). 2290926–2290926. 2 indexed citations
5.
Huang, Jiaofeng, et al.. (2022). The association between Toxoplasma infection and mortality: the NHANES epidemiologic follow-up study. Parasites & Vectors. 15(1). 284–284. 10 indexed citations
6.
Huang, Jiaofeng, Yinlian Wu, Ming-Fang Wang, Yueyong Zhu, & Su Lin. (2022). Lower Vitamin D Levels are Associated with Higher Seroprevalence of Toxoplasma gondii—a US National Survey Study. SHILAP Revista de lepidopterología. 2(1). 3 indexed citations
7.
Chen, Xiaoning, George Boon‐Bee Goh, Jiaofeng Huang, et al.. (2022). Validation of Non-invasive Fibrosis Scores for Predicting Advanced Fibrosis in Metabolic-associated Fatty Liver Disease. Journal of Clinical and Translational Hepatology. 10(4). 589–594. 15 indexed citations
8.
Huang, Jiaofeng, Ming-Fang Wang, Yinlian Wu, Rahul Kumar, & Su Lin. (2022). Serum high-sensitive C-reactive protein is a simple indicator for all-cause among individuals with MAFLD. Frontiers in Physiology. 13. 1012887–1012887. 15 indexed citations
9.
Huang, Jiaofeng, Yinlian Wu, Ming-Fang Wang, & Su Lin. (2022). The association between serum 25‐hydroxyvitamin D and the prevalence of herpes simplex virus. Journal of Medical Virology. 95(1). e28297–e28297. 6 indexed citations
10.
Zeng, Danyi, Su Lin, Xuan Dong, et al.. (2021). Global burden of acute viral hepatitis and its association with socioeconomic development status, 1990–2019. Journal of Hepatology. 75(3). 547–556. 98 indexed citations
11.
Lin, Su, et al.. (2020). Clinical Analysis of the Curative Effect of a Transnasal Ileus Tube in the Treatment of Small Bowel Obstruction Caused by a Phytobezoar. Gastroenterology Research and Practice. 2020. 1–8. 3 indexed citations
12.
Lin, Su, et al.. (2020). The Risk of Acute Kidney Injury in Hepatitis B Virus‐Related Acute on Chronic Liver Failure with Tenofovir Treatment. BioMed Research International. 2020(1). 5728359–5728359. 5 indexed citations
13.
Wan, Bo, Su Lin, Ming-Fang Wang, et al.. (2018). Procalcitonin and Liver Disease: A Literature Review. Journal of Clinical and Translational Hepatology. 7(1). 51–55. 48 indexed citations
14.
Wang, Ming-Fang, et al.. (2018). Efficacy and safety of autologous stem cell transplantation for decompensated liver cirrhosis: A retrospective cohort study. World Journal of Stem Cells. 10(10). 138–145. 8 indexed citations
15.
Lin, Su, Ming-Fang Wang, Yueyong Zhu, et al.. (2015). Hemorrhagic complications following abdominal paracentesis in patients with acute-on-chronic liver failure. 33(5). 262–265. 3 indexed citations
16.
Lin, Su. (2015). Analysis onRecent Infected HIV-1Patients among Newly Reported HIV Cases in Sichuan from 2010-2014. Chinese Journal of AIDS & STD. 1 indexed citations
17.
Lin, Su, Zhiyuan Weng, Jing Xu, et al.. (2013). A study of multiple biliary hamartomas based on 1697 liver biopsies. European Journal of Gastroenterology & Hepatology. 25(8). 948–952. 16 indexed citations
18.
Lin, Su. (2007). Personality Characteristics of Middle School Students with Internet Overuse Trend. Zhongguo xinli weisheng zazhi. 1 indexed citations
19.
Lin, Su. (2007). Study on the Suicide Idea and Its Influence Factors among Middle School Students at the Urban Area in Fuzhou in 2005. 1 indexed citations
20.
Sperber, Kirk, Michael J. Louie, Thomas Kraus, et al.. (1995). Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1. Clinical Therapeutics. 17(4). 622–636. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026